{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:04:46Z","timestamp":1788203086510,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107D36-003-MY2-2"],"award-info":[{"award-number":["V107D36-003-MY2-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-050"],"award-info":[{"award-number":["V108C-050"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107C-113"],"award-info":[{"award-number":["V107C-113"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHUST108-G6-1-2"],"award-info":[{"award-number":["VGHUST108-G6-1-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["MOHW107-TDU-B-211-114019"],"award-info":[{"award-number":["MOHW107-TDU-B-211-114019"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-038-030"],"award-info":[{"award-number":["MOST 106-2314-B-038-030"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jfma.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:13:55Z","timestamp":1568852035000},"page":"610-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis"],"prefix":"10.1016","volume":"119","author":[{"given":"Chien-Wei","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chieh","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jfma.2019.09.003_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jfma.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000452846","article-title":"Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan society of hepatology: a comparison with the liver damage and child-pugh classifications","volume":"6","author":"Hiraoka","year":"2017","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.jfma.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jfma.2017.09.007","article-title":"Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan liver cancer association and the gastroenterological society of Taiwan","volume":"117","author":"Surveillance Group","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jfma.2019.09.003_bib4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/hep.29321","article-title":"Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population","volume":"66","author":"Choi","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"issue":"10127","key":"10.1016\/j.jfma.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (Lond, Engl)"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000479984","article-title":"Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function","volume":"6","author":"Hiraoka","year":"2017","journal-title":"Liver Cancer"},{"issue":"7","key":"10.1016\/j.jfma.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2019.09.003_bib9","doi-asserted-by":"crossref","first-page":"42577","DOI":"10.1038\/srep42577","article-title":"The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma","volume":"7","author":"Hsieh","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jfma.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000485471","article-title":"Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit\/risk assessment","volume":"7","author":"Piscaglia","year":"2018","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib11","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/hep.26256","article-title":"The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"57","author":"Sieghart","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.jfma.2019.09.003_bib12","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/annonc\/mdt247","article-title":"A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer","volume":"24","author":"Kadalayil","year":"2013","journal-title":"Ann Oncol \u2013 Offic J Eur Soc Med Oncol"},{"issue":"1","key":"10.1016\/j.jfma.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jhep.2015.02.034","article-title":"Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"63","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.jfma.2019.09.003_bib15","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.cgh.2015.07.012","article-title":"Varices and variceal hemorrhage in cirrhosis: a new view of an old problem","volume":"13","author":"Garcia-Tsao","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib16","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s00330-016-4604-z","article-title":"The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis","volume":"27","author":"Fang","year":"2017","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jfma.2019.09.003_bib17","first-page":"729","article-title":"Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma","volume":"36","author":"Cappelli","year":"2016","journal-title":"Liver Int \u2013 Offic J Int Assoc Study Liver"},{"issue":"3","key":"10.1016\/j.jfma.2019.09.003_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0016-5107(81)73224-3","article-title":"Prediction of variceal hemorrhage by esophageal endoscopy","volume":"27","author":"Beppu","year":"1981","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jfma.2019.09.003_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jfma.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","article-title":"Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas","volume":"9","author":"Hung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.jfma.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jfma.2019.09.003_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gie.2017.12.023","article-title":"Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices","volume":"88","author":"Chen","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"21","key":"10.1016\/j.jfma.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jfma.2019.09.003_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jfma.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1245\/s10434-014-4221-5","article-title":"Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection","volume":"22","author":"Su","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.jfma.2019.09.003_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1148\/radiol.2017162382","article-title":"Hepatocellular carcinoma: nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation","volume":"285","author":"Kao","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jfma.2019.09.003_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","article-title":"Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study","volume":"62","author":"Vitale","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2016.07.020","article-title":"Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: the GIDEON study","volume":"65","author":"Marrero","year":"2016","journal-title":"J Hepatol"},{"issue":"10126","key":"10.1016\/j.jfma.2019.09.003_bib31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet (Lond, Engl)"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/apt.14913","article-title":"Review article: systemic treatment of hepatocellular carcinoma","volume":"48","author":"Pinter","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jfma.2019.09.003_bib33","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/apt.14066","article-title":"Review article: delivering precision oncology in intermediate-stage liver cancer","volume":"45","author":"Pinato","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jfma.2019.09.003_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","article-title":"The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma","volume":"66","author":"Pinato","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000487407","article-title":"The prognosis of single large hepatocellular carcinoma was distinct from Barcelona clinic liver cancer stage a or B: the role of albumin-bilirubin grade","volume":"7","author":"Fang","year":"2018","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.jfma.2019.09.003_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2014.11.014","article-title":"Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process","volume":"62","author":"Adhoute","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2019.09.003_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MCG.0b013e318210ff17","article-title":"Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction","volume":"45","author":"Hsin","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jfma.2019.09.003_bib38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664619304772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664619304772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:07:26Z","timestamp":1778515646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664619304772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0929664619304772"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2019.09.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}